Vertaling van "respiratory diseases " (Frans → Nederlands) :

TERMINOLOGIE

virus Borna disease
Borna disease-virus

virus Epizootic hemorrhagic disease, New Jersey
epizootisch hemorrhagische ziekte, New Jersey-virus

virus Lymphocystis disease
Lymfocytaire virusziekte

virus Jembrana disease
Jembrana-virusziekte

rippling muscle disease avec myasthenia gravis
immuun-gemedieerde golvende spierziekte

virus Border disease
Border disease-virus

virus Bovine mucosal disease
bovien mucosal disease-virus

rippling muscle disease
rippling muscle-ziekte

virus Nairobi sheep disease
Nairobi sheep disease-virus

IN-CONTEXT TRANSLATIONS

Source Statement ACA Not included ACP Not included ASA Selected patients : Agreement : 90 % of consultants, 92 % ASA Members To consider : smoking, recent infection, COPD, and cardiac disease ICSI Selected patients with signs or symptoms suggesting new or unstable cardiopulmonary disease INAHTA Chest X-ray abnormality correspond more closely with ASA status than with age (McCleane) i The results of between 0% and 2.1% of chest X-rays leads to a change in management There is no published evidence that routine preoperative chest X-rays decrease perioperative risks ii . NICE Minor surgery: ASA I : not indicated ASA II : consider > 40 y if respiratory or CV disease ASA III : consider if respiratory or CV disease Intermediate surgery: ASA I : not indicated ASA II : consider if respiratory or CV disease (renal > 60y) ASA III : consider if respiratory, CV or renal disease Major surgery: ASA I : consider > 60 ASA II : consider if respiratory, CV or renal disease ASA III : consider if respiratory, CV or renal disease
Source Statement ACA Not included ACP Not included ASA Selected patients : Agreement : 90 % of consultants, 92 % ASA Members To consider : smoking, recent infection, COPD, and cardiac disease ICSI Selected patients with signs or symptoms suggesting new or unstable cardiopulmonary disease INAHTA Chest X-ray abnormality correspond more closely with ASA status than with age (McCleane) i The results of between 0% and 2.1% of chest X-rays leads to a change in management There is no published evidence that routine preoperative chest X-rays decrease

e) présenter au «Chronic Respiratory Disease Questionnaire» (CRDQ) un score total inférieur à 100 pour l'ensemble des dimensions " dyspnée" , " fatigue" , " émotions" et " maîtrise" , ou un score inférieur à 20 pour la dimension " dyspnée"
e) bij de «Chronic Respiratory Disease Questionnaire» (CRDQ) een totaal-score hebben van minder dan 100 voor het geheel van de dimensies " dyspnee" , " vermoeidheid" , " emoties" en " beheersing" , of een score van minder dan 20 voor de dimensie " dyspnee" .

tombant sous un des chapitres suivants du ‘International Classification of Diseases’: 001-139 Certain infectious and parasitic diseases, II 140-239 Neoplasms, III 240-279 Endocrine, nutritional and metabolic diseases and Immunity disorders, IV 280-289 Diseases of the blood and blood-forming organs, VI 320-359 Diseases of the nervous system, VII 390-459 Diseases of the circulatory system, VIII 460-519 Diseases of the respiratory system, IX 520-579 Diseases of the digestive system, X 580-629 Diseases of the genitourinary system, XII 680-709 Diseases of the skin and subcutaneous tissue, XIII 710-739 Diseases of the musculoskeletal system and connective tissue, XVI 780-799 Symptoms, and ill defined conditions, XVII 800-999 Injury, poisoning.
de volgende hoofdstukken van de ‘International Classification of Diseases’: 001-139 Certain infectious and parasitic diseases, II 140-239 Neoplasms, III 240-279 Endocrine, nutritional and metabolic diseases and Immunity disorders, IV 280-289 Diseases of the blood and blood-forming organs, VI 320-359 Diseases of the nervous system, VII 390- 459 Diseases of the circulatory system, VIII 460-519 Diseases of the respiratory system, IX 520-579 Diseases of the digestive system, X 580-629 Diseases of the genitourinary system, XII 680-709 Diseases of the skin and subcutaneous tissue, XIII 710-739 Diseases of the musculoskeletal system and connective tissue, XVI 780-799 Symptoms, and ill defined conditions, XVII 800-999 Injury, poisoning.

Novartis Pharma commercialise des médicaments de marque dans 8 domaines thérapeutiques : Cardiovascular & Metabolism, Oncology & Hematology, Neurosciences, Respiratory, Immune & Infectious Disease, Ophthalmology, Dermatology, Arthritis & Bone.
Novartis Pharma commercialiseert merkgeneesmiddelen voor 8 therapeutische vakgebieden: Cardiovascular & Metabolism, Oncology & Hematology, Neurosciences, Respiratory, Immune & Infectious Disease, Ophthalmology, Dermatology, Arthritis & Bone.

risk of allergic and respiratory diseases later in childhood (Bernard et al., 2007) Cette étude vérifie l’effet de la natation chez les bébés sur la prévalence d’allergie et l’état de santé sur le plan respiratoire à l’âge de 10-13 ans.
of allergic and respiratory diseases later in childhood (Bernard et al., 2007) In deze studie wordt het effect van babyzwemmen nagegaan op de prevalentie van allergie en de respiratoire gezondheidstoestand op de leeftijd van 10 tot 13 jaar.

folding and its platform for drug and target discovery, the company is building a pipeline, initially for neurodegenerative and respiratory conditions. FoldRx’s pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, Transthyretin (TTR) Amyloid Polyneuropathy (ATTR-PN) and TTR Amyloid Cardiomyopathy (ATTR-CM), and a discovery program in cystic fibrosis, Parkinson’s, and Huntington’s disease based on its broad, proprietary, yeast-based drug discovery platform.
FoldRx is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis) based on the pioneer work of its scientific founders, Jeffery Kelly (The Scripps Research Institute) and Susan Lindquist (Whitehead Institute).

- il s'agit d'un médicament de la liste suivante de codes ATC: R01 Nasal preparations, R03 Drugs for obstructive airway diseases, R05 Cough and cold preparations; R06 Antihistamines for systemic use, R07 Other respiratory system products, S01G Decongestants and antiallergics.
- het betreft een geneesmiddel uit volgende lijst ATC codes: R01 Nasal preparations, R03 Drugs for obstructive airway diseases, R05 Cough and cold preparations; R06 Antihistamines for systemic use, R07 Other respiratory system products, S01G Decongestants and antiallergics.